Gilead Sciences (NASDAQ:GILD) reported quarterly earnings of $2.65 per share which beat the analyst consensus estimate of $1.74 by 52.3 percent. This is a 25.59 percent increase over earnings of $2.11 per share from the same period last year. The company reported quarterly sales of $7.40 billion which beat the analyst consensus estimate of $6.25 billion by 18.40 percent. This is a 12.51 percent increase over sales of $6.58 billion the same period last year.
Gilead Sciences Q3 EPS $2.65 Beats $1.74 Estimate, Sales $7.40B Beat $6.25B Estimate
Gilead Sciences (NASDAQ:GILD) reported quarterly earnings of $2.65 per share which beat the analyst consensus estimate of $1.74 by 52.3 percent. This is a 25.59 percent increase over earnings of $2.11 per share from the
